Book Description
This digital document is an article from Business North Carolina, published by Business North Carolina on August 1, 2004. The length of the article is 598 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Digital Locker immediately after purchase. You can view it with any web browser.Citation Details
Title: Triad.(Regional Report)(TriPath Imaging wins approval for screening kit collection devices)(Hillerich & Bradsby buys Practice Partner's baseball equipment business)(Rheem Manufacturing plans warehouse in Randleman, NC)
Publication: Business North Carolina (Magazine/Journal)
Date: August 1, 2004
Publisher: Business North Carolina
Volume: 24 Issue: 8 Page: 13(1)Distributed by Thompson Gale

Excerpt. © Reprinted by permission. All rights reserved.

BURLINGTON -- TriPath Imaging, which makes cancer-screening products, won approval from the U.S. Food and Drug Administration to use two more kinds of cell-collection devices with its cervical-cancer screening kits. The approval should make the kits more market-able to doctors who prefer those devices. TriPath's kit was approved in 1999 for use with one of the three main collection devices used by doctors in cervical-cancer screening. TriPath reported revenue of $53.8 million in 2003.